Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oliceridine vs Tegileridine for postoperative analgesia in elderly abdominal surgery
ChiCTR2600125246Phase 4Not yet recruiting
- Sponsor
- Cangzhou Central Hosptial
- Start
- May 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of oliceridine in postoperative pain (2 arms), sponsored by Cangzhou Central Hosptial. Primary endpoint: Achievement rate of pain score control at 48 h after surgery. Planned start May 2026; status: not yet recruiting.
02
Drugs
oliceridine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2600125246.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600125246.